8:20 PM
 | 
Aug 16, 2018
 |  BC Week In Review  |  Company News  |  Deals

Juvenescence, partners form anti-aging biotech

Juvenescence Ltd. (Douglas, Isle of Man), Insilico Medicine Inc. (Baltimore, Md.) and the Buck Institute for Research on Aging (Novato, Calif.) partnered to form anti-aging company Napa Therapeutics Ltd. (Tortola, British Virgin Islands).

Napa will use Insilico's deep learning platform to discover small molecules against an undisclosed aging-related target in collaboration with Buck Institute President and CEO Eric Verdin's lab.

The newco is based on research from Verdin's...

Read the full 316 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >